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Leishmaniases are a group of diseases caused by protozoa of the genus Leishmania that
affect millions of people worldwide. These diseases are caused by distinct Leishmania
species, of which L. braziliensis, a NewWorld representative of the Leishmania genus, has
been the least studied. Although leishmaniasis caused by L. braziliensis induces a range of
clinical manifestations ranging from mild localized lesions to severe mucosal involvement,
few studies have focused on elucidating the immune mechanisms behind this pathology.
In this review, we focus on the immunobiology of L. braziliensis infection, emphasizing
the innate and adaptive immune responses and taking into consideration both studies
performed in endemic areas and experimental models of infection. Additionally, we address
recent ﬁndings regarding the role of sand ﬂy saliva in disease immunopathogenesis and
vaccine development.
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INFECTION WITH NEWWORLD LEISHMANIA SPECIES:
CLINICAL ASPECTS
Rebelo et al. (2010) proposed the term tegumentary (skin or
mucosal) leishmaniasis (TL) to the French Society of Derma-
tology in 1925, the ﬁrst contribution of Brazilian researchers
to the study of this disease. TL is a major health problem in
Brazil, where the main Leishmania species associated with this
disease are Leishmania (Viannia) braziliensis, L. (V.) naifﬁ, L. (V.)
shawi, L. (V.) lainsoni, and L. (Leishmania) amazonensis. Of these,
L. braziliensis is the predominant species in the regions of Brazil
where TL is endemic, and it occurs in areas of both ancient
and recent colonization with a low prevalence in the Amazonas
state (Jones et al., 1987). L. braziliensis transmission is associated
with the presence of domestic animals, which are implicated as
potential reservoirs. It is transmitted by several different sand ﬂy
species, including Lutzomyia intermedia, Lu. whitmani, and Lu.
wellcomei (Miranda et al., 2002; Rebelo et al., 2010). L. amazo-
nensis has been identiﬁed in different areas of Brazil and induces
cutaneous ulcers, including diffuse cutaneous leishmaniasis. The
main reservoirs for L. amazonensis are rodents and marsupi-
als, and the main vector species associated with its transmission
are Lu. ﬂaviscutellata and Lu. olmeca. Host–parasite interactions
can lead to a series of events culminating in clinical manifesta-
tions; the clinical forms of TL vary due to this complexity. In
Brazil, TL can present as a single lesion (LCL, localized cuta-
neous leishmaniasis) that can be unapparent or discrete and can
spontaneously heal. Multiple ulcerations may be present, com-
promising the mucosal areas (ML, mucosal leishmaniasis). ML
is particularly important in South America and is caused pri-
marily by L. braziliensis, although L. amazonensis has also been
implicated (Costa et al., 1986). ML is characterized by latency and
chronicity. Parasitological diagnosis is difﬁcult, and a signiﬁcant
number of cases do not respond to treatment. Generally, 2–5%
of TL cases in which the primary infection heals subsequently
develop ML (Marsden, 1990). Leishmania persistence following
clinical treatment may be responsible for recurrence of the dis-
ease (Schubach et al., 1998). LCL and ML represent responsive
facets of the disease, with immune responses that are readily
detected.
Diffuse cutaneous leishmaniasis, caused by L. amazonensis, is a
rare but severe manifestation of the disease that develops in aner-
gic patients and is characterized by a defective cellular immune
response to Leishmania antigens (Convit et al., 1962). In this
case, a single ulcer slowly evolves, developing plaques or multiple
non-ulcerated nodules. Diffuse cutaneous leishmaniasis responds
poorly to treatment, and Leishmania skin tests are negative.
In this review, we will focus on recent advances in under-
standing the complexity of TL caused by L. braziliensis, focusing
on both experimental models of infection and pathogenesis in
the human host. We will also discuss certain aspects of infec-
tion with L. amazonensis, given its sole association with diffuse
cutaneous leishmaniasis and the singular characteristics of this
disease. We aim to provide a current picture of the complex host–
parasite interactions involved in leishmaniasis while also taking
into account the role of the vector’s saliva, an area of intense
research in the past several years.
It is important to understand recent ﬁndings regarding intrin-
sic differences within the Leishmania species when addressing
L. braziliensis pathogenesis. These differences came to light follow-
ing vaccination attempts using the L. braziliensis homologs of the
receptor for activated C kinase (LACK), thiol-speciﬁc antioxidant
(TSA), Leishmania elongation and initiation factor (LeIF1), and
L. major stress-inducible protein 1 (LmSTI1; Salay et al., 2007). All
four open reading frames have a high degree of homology at the
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amino acid level with previously described L. major genes. How-
ever, immunization failed to signiﬁcantly reduce lesions following
challenge with L. braziliensis.
A comparison between the genomes of L. (L.) major, L. (L.)
infantum chagasi, and L. braziliensis showed elevated gene syn-
teny, expected for species belonging to the same genus, with
only 200 genes differentially distributed between the three species.
Moreover, few genes are species-speciﬁc, and only 47 genes are
speciﬁc to L. braziliensis. However, the greatest surprise was
that genes related to RNAi machinery have only been found in
L. braziliensis (Peacock et al., 2007). Mobile elements such as
retrotransposons were also identiﬁed in L. braziliensis but are
absent in L. major and L. infantum, both of which are RNAi-
deﬁcient (Peacock et al., 2007) Importantly, the RNAi machinery
in L. braziliensis is functional (Lye et al., 2010) enabling the down-
regulation of reporter and endogenous genes. The RNAi pathway
in L. braziliensis could potentially help protect against mutations
caused by mobile elements (Shi et al., 2004). Double-strand (ds)
RNA viruses (LRVs) can infect L. braziliensis (Tarr et al., 1988;
Patterson, 1993), and the RNAi response may help to pro-
tect against such infection (Anderson et al., 2007). However,
infection with LRV increased parasite survival and pathogen-
esis in L. guyanensis (Ives et al., 2011), raising the possibility
that, in RNAi-competent Leishmania, LRV infection may actually
down-modulate RNAi activity.
INNATE IMMUNITY IN LEISHMANIASIS TRIGGERED
BY L. BRAZILIENSIS
BALB/c mice infected in the ear dermis with L. braziliensis develop
cutaneous lesions at the site of inoculation (de Moura et al., 2005),
and histological analysis of ear sections demonstrated constant
recruitment of neutrophils to the inoculation site. Interestingly,
neutrophil depletion during L. braziliensis infection increased par-
asite load, whereas BALB/c mice co-inoculated with both parasites
and live neutrophils displayed lower parasite loads at the site of
infection and in the draining lymph nodes (Novais et al., 2009). In
vitro, co-cultures of live neutrophils and L. braziliensis-infected
macrophages led to a decrease in parasite load, and elimina-
tion of L. braziliensis elimination was associated with TNF-α and
superoxide production (Novais et al., 2009). In experiments using
L. amazonensis, phagocytosis of apoptotic human neutrophils by
L. amazonensis-infected macrophages led to an increase in para-
site burden in a TGF-β and PGE2-dependent manner. Conversely,
uptake of necrotic neutrophils by infected macrophages led to
killing of L. amazonensis. Leishmanicidal activity was depen-
dent on TNF-α and neutrophil elastase and was also associated
with superoxide production (Afonso et al., 2008). Another func-
tion attributed to the neutrophils is the production of neutrophil
extracellular traps (NETs) which are composed of ﬁlamentous
genomic DNA containing antimicrobial peptides. L. amazonensis
parasites are susceptible to killing by humans NETs, and LPG iso-
lated from these parasites triggeredNET release (Guimaraes-Costa
et al., 2009).
L. braziliensis induced the production of CXCL-10 and IL-10
by human peripheral blood mononuclear cells (PBMCs) and
macrophages, but the enhanced expression of CXCL10 and
its receptor, CXCR3, was predominantly detected in CD14+
monocytes. Interestingly, sera from TL patients, and espe-
cially those from ML patients, have signiﬁcantly higher levels of
CXCL10, CCL4, and soluble TNF receptor II (sTNFRII) than sera
from control individuals. These multiple inﬂammatory media-
tors produced by the host may contribute to disease severity by
increasing cellular recruitment (Vargas-Inchaustegui et al., 2010).
However, IL-10 production is important in controlling the exac-
erbated inﬂammatory response characteristic of TL. Antonelli
et al. (2004) showed a strong positive correlation between IL-10
and TNF-α-producing monocytes in PBMC cultures from LCL
patients stimulated with soluble Leishmania antigen (SLA), sug-
gesting that an intrinsic macrophage auto-regulation mechanism
appears to be active in LCL patients.
Interferon-β increases the parasite load in infected human
macrophages following infection with New World parasites
(L. braziliensis and L. amazonensis) in a manner that is indepen-
dent of endogenous and exogenous NO (Khouri et al., 2009). In
parallel, IFN-β signiﬁcantly reduces superoxide release by both
Leishmania-infected and uninfected human macrophages. This
reduction was accompanied by a signiﬁcant increase in superoxide
dismutase (SOD1) protein levels. Biopsies from New World cuta-
neous leishmaniasis patients show pronounced SOD-1 expression
levels in situ (Khouri et al., 2009). Importantly, these results suggest
that IFN-β production in human Leishmaniasis may be deleteri-
ous, particularly in DCL cases where the parasite load is elevated.
Similarly, TGF-β also plays a major role in macrophage deactiva-
tion, leading to increased parasite load in an experimental model
of L. amazonensis infection (Barral et al., 1992). Subsequently, par-
asite killing following L. amazonensis infection has been observed
in vitro in experiments using the superoxide-dismutase inhibitor
diethyldithiocarbamate (DETC; Khouri et al., 2010). Moreover, in
vivo treatment with DETC signiﬁcantly decreased lesion size and
parasite load in an experimental model of L. braziliensis infection.
Systemic administration of Leishmania parasites, including
L. braziliensis, induces in vivo DC maturation characterized by
DC migration to T cell areas and costimulatory molecule upregu-
lation (Antonelli et al., 2004). DCs co-cultured with L. braziliensis
up-regulate DC activationmarkers and produce IL-12 and TNF-α.
However, up-regulation of activation markers and IL-12 pro-
duction was primarily conﬁned to bystander (uninfected) DCs
(Carvalho et al., 2008). The authors of this study proposed that
bystander DCs in L. braziliensis infection lead to T cell activa-
tion, while infected DCs contribute to parasite control through
enhanced TNF-α production. Indeed, experimentally infected
TNF-α−/− mice developed non-healing skin lesions (Rocha et al.,
2007). Likewise, axenic L. braziliensis amastigotes successfully
stimulated DCs to produce IL-12p40, inducing an activated
phenotype (Vargas-Inchaustegui et al., 2008). DCs infected with
L. braziliensis show increased phosphorylation of STAT molecules
and ISG15 expression (IFN-stimulated gene 15). Accordingly, in
vivo infection with L. braziliensis led to a self-healing phenotype
characterized by increased numbers of IFN-γ- and IL-17-secreting
CD4+ T cells. DCs from MyD88−/− mice exhibited less acti-
vation and decreased production of IL-12 during experimental
L. braziliensis infection, suggesting a role for TLR involvement
(Vargas-Inchaustegui et al., 2009). Furthermore, MyD88−/− mice
developed larger lesions than control mice. However, a lack of
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TLR2 resulted in enhanced DC activation, increased IL-12 pro-
duction and successful priming of naïve CD4+ T cells. Fully
understanding the role of TLRs in L. braziliensis infection will
require further research.
ADAPTIVE IMMUNITY IN HUMAN LEISHMANIASIS
In general, patients with LCL and ML have a strong type 1 immune
response to Leishmania antigen, with high production of IFN-γ
and TNF-α and decreased efﬁcacy of IL-10 in down-modulating
IFN-γ production (Follador et al., 2002). With disease progres-
sion, ML patients tend to develop stronger intradermal skin test
reactions, and their lymphocytes exhibit stronger proliferative
responses and IFN-γ production than cells from LCL patients.
However, antigen-stimulated PBMCs from 50% of subjects who
developed the disease within the previous 60 days exhibit low
or absent IFN-γ levels. This response can be restored by either
IL-12 or anti-IL-10monoclonal antibodies (Ribeiro-de-Jesus et al.,
1998). Later in the disease course, both LCL and MCL patients
exhibited high levels of IFN-γ and TNF-α, but TNF-α levels
decreased following treatment. IFN-γ and TNF-α seem to be
involved in both controlling parasite multiplication during the
early phases of Leishmania infection and mediating the tissue
damage observed in TL (Ribeiro-de-Jesus et al., 1998). In a recent
study,Oliveira et al. (2011) observed a positive correlation between
ulcer size at the time of the ﬁrst evaluation, time to recovery, and
TNF-α levels, supporting the use of TNF-α inhibitors combined
with standard therapy to improve recovery time in LCL patients
with severe lesions. In fact, pentoxifylline has been successfully
used to decrease recovery time in ML patients, even in those
that were refractory to conventional treatment (Lessa et al., 2001;
Baﬁca et al., 2003).
Infection with L. braziliensis has been associated with lym-
phadenopathy in the absence of tegumentary lesions (skin or
mucosal; Barral et al., 1992, 1995a). Lymphadenopathy can pre-
cede the appearance of skin ulcers and must be differentiated from
the satellite lymph node enlargement associated with lesion estab-
lishment. Cells obtained from lymph nodes from LCL patients
without ulcerations (early phase) exhibited a higher propor-
tion of neutrophils, eosinophils, and CD8+ T cells. In contrast,
CD19+ B cells and plasma cells were more frequently observed in
patients showing lymphadenopathy with ulcerations (late phase;
Bomﬁm et al., 2007). IL-10 transcription was signiﬁcantly higher
in late-phase disease, suggesting an important role for this cytokine
in limiting tissue damage. IFN-γ and IL-4 levels were simi-
lar in both groups of patients, reinforcing the concept of a
mixed Th1–Th2 proﬁle during disease. These results highlight
the role of CD8+ T cells in the early phase of CL, as shown by
Pompeu et al. (2001) using a model of in vitro priming. Addition-
ally, there is a temporal relationship between ulcer development
and the increasednumbers of B cells. Cells frompatients exhibiting
ulcers typical of LCL-produced IFN-γ and TNF-α upon stimula-
tion with SLA or LACK, which originated from multiple sources,
including CD4+ and CD8+ T cells (Bottrel et al., 2001). A pos-
itive correlation was observed between IFN-γ or TNF-α and
IL-10 production from lymphocytes. Higher frequencies of IL-10-
producing parasite-speciﬁc lymphocytes are correlated with lower
frequencies of TNF-α-producing monocytes, demonstrating the
role of antigen-speciﬁc IL-10 production in negatively regulating
monocyte activity (Antonelli et al., 2004, 2005).
Studies of different Vβ T cells in LCL patients have revealed
an association between TCR Vβ 12 expressions, T cell activa-
tion and IFN-γ production after in vitro priming with Leishmania
(Clarencio et al., 2006). More recently, Keesen et al. (2011) mea-
sured the expansion, activation state, and functional potential
of speciﬁc T cells identiﬁed by their TCR Vβ expression. They
observed an increase in CD4 Vβ 5.2- and Vβ 24-positive T cells in
LCL patients compared to controls, a proﬁle suggesting previous
activation of the CD4 Vα 5.2-, 11-, and 24-positive T cells char-
acterized by increased expression of CD45RO, HLA-DR, IFN-γ,
TNF-α, and IL-10 compared to the other Vβ-expressing subpop-
ulations and a positive correlation between higher frequencies
of CD4 Vβ 5.2 T cells and lesion size. The identiﬁcation of
active subpopulations in this form of the disease could allow for
the identiﬁcation of the immunodominant Leishmania antigens
responsible for triggering an efﬁcient host response against thepar-
asite and could also allow for identiﬁcation of the cell populations
involved in disease pathology.
In L. braziliensis endemic areas, approximately 10% of the indi-
viduals have a positive delayed-type hypersensitivity (DTH) skin
test to Leishmania antigen but have neither a previous history of
LCL nor a typical LCL scar. These individuals are categorized as
having a subclinical (SC) L. braziliensis infection (Follador et al.,
2002). Individuals with SC L. braziliensis infection produce sig-
niﬁcantly lower levels of IFN-γ and TNF-α than patients with
active LCL. However, IL-10 levels are higher in these individuals
than in LCL patients (Bittar et al., 2007). Recently, Novoa et al.
(2011) reported stronger Th1 responses in LCL patients than in
SC individuals. This ﬁnding seems be unaffected by IL-10, as lev-
els of this cytokine at both the protein and mRNA levels were
very similar in both groups. IL-27 is a cytokine that both initi-
ates a Th1 response and regulates inﬂammation (Trinchieri et al.,
2003; Yoshimura et al., 2006). IL-27 mRNA levels were higher in
cells from LCL patients than in those from SC patients follow-
ing stimulation with L. braziliensis. The mechanisms by which
SC individuals control parasite growth are unknown. Because the
adaptive immune responses in these individuals is less prominent,
we can speculate that parasite control may be dependent on innate
immune responses, with the participation of neutrophils (Novais
et al., 2009), macrophages, and NK cells of particular importance.
Interestingly, PBMC IL-17 production is slightly higher in SC
patients than in LCL patients, suggesting a possible protective
role for this cytokine. However, IL-17 could be exerting differ-
ent functions based on the phase of disease. Our group recently
illustrated the involvement of IL-17 and IL-17-inducing cytokines
in biopsy specimens from ML patients. IL-17 was expressed by
CD4+, CD8+, and CD14+ cells, and numerous IL-17+ cells
co-expressed CCR6. We also observed the presence of neu-
trophils in necrotic and perinecrotic areas; these neutrophils
stained positive for neutrophil elastase, myeloperoxidase, and
MMP-9, indicating that IL-17 could be involved in ML patho-
genesis (Boaventura et al., 2010). In fact, in vitro infec-
tion of human macrophages with L. braziliensis increased the
secretion and activation of MMP-9, and macrophages from
cured individuals with previous histories of ML exhibited
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increased MMP-9 activity than those from cured LCL patients
(Maretti-Mira et al., 2011).
Mucosal leishmaniasis patients display an exacerbated and
unregulated immune response. They have a higher frequency of
activated T cells than patients with LCL, as measured by differ-
ent activation markers. While LCL patients displayed a positive
correlation between IL-10 and TNF-α-producing monocytes, ML
patients did not. This lack of correlation between IL-10-producing
and TNF-α producing monocytes in ML patients could lead to a
poorly controlled inﬂammatory response in vivo, and cytokine
networks may be involved in the development of immunopathol-
ogy in ML patients (Gaze et al., 2006). Additionally, IL-10
receptor expression was lower in ML lesions than in LCL lesions
(Faria et al., 2005).
ROLE OF CD8+ T CELLS
The role of cytotoxicity in host defense and tissue damage dur-
ing human LCL is not yet well understood. Machado et al. (2002)
observed the presence of NK cells, CD8+ and CD45RO+ T cells,
and strong expression of TIA-1, a molecule associated with cyto-
toxicity, in the dermal cell inﬁltrates of lesions from LCL patients.
The presence of these cytolytic cells in LCL lesions suggests active
participation of NK and CD8+ T cells in the pathogenesis of this
disease. These cells may play a role in both parasite killing and
ulcer development (Machado et al., 2002). More recently, Faria
et al. (2009) characterized the immunological kinetics associated
with LCL progression, comparing the cellular composition and
cytokine and granzyme expression in lesions of patients with
early-stage (E-LCL) and late-stage LCL (L-LCL). Histopatholog-
ical analysis showed that lesions from L-LCL patients displayed
more exuberant inﬂammatory inﬁltration than those from E-LCL
patients. Although E-LCL and L-LCL lesions were predominantly
mononuclear, lesions from E-LCL patients presented higher neu-
trophil and eosinophil counts than those from L-LCL patients.
CD8+ T cells from L-LCL lesions expressed signiﬁcantly higher
levels of granzyme A than those from E-LCL lesions. Interest-
ingly, granzyme A expression was positively correlated with the
intensity of the inﬂammatory inﬁltrate in L-LCL patients but not
in E-LCL patients. These results suggest that the recruitment of
CD8+ and granzyme A+ T cells is involved in lesion progression
in human LCL. Our group found similar results, showing that
lesions from CL patients presented higher frequencies of CD8+
T cells displaying CLA (cutaneous lymphocytes antigen); these
cells are mainly cytolytic, with strong expression of CD107 and
granzyme B. They also produce IFN-γ and IL-10, but in lower fre-
quencies than CD4+ T cells (Silva et al., submitted manuscript).
Mendes-Aguiar Cde et al. (2009) also observed that theCLA recep-
tor could direct Leishmania-speciﬁc CD8+ T lymphocytes toward
inﬂamed skin lesions, suggesting that Leishmania antigens could
modulate the molecules responsible for skin lesions, affecting the
cell composition of the inﬂammatory inﬁltrate in Leishmaniasis.
CD8+ T cells seem to play distinct roles in different phases of
the disease. Using an in vitro priming assay (IVP), we observed
that CD8+ T cells are the ﬁrst cells to be activated by Leishmania
promastigotes and to produce IFN-γ, which is partially respon-
sible for directing the differentiation of Th1 cells (Pompeu et al.,
2001). However, CD8+ T cells and NK cells also contribute to the
tissue destruction observed in ML patients in late stages of disease
(Brodskyn et al., 1997).
IMMUNOSUPPRESSION IN LEISHMANIASIS
In spite of a robust immune response, a small number of parasites
persist following the resolution of leishmaniasis (Mendonca et al.,
2004; Figueroa et al., 2009; Martins et al., 2010). In mice infected
with L. braziliensis in the ear dermis, parasites also persist in drain-
ing lymph nodes, despite lesion resolution and parasite clearance
from the infection site (de Moura et al., 2005). In mice, IL-10
blockade following infection with low doses leads to a sterile cure
of the disease (Belkaid et al., 2001). In Leishmaniasis, this cytokine
can be produced by several different cell sources, including Treg
cells (Belkaid et al., 2002), Th1 cells (Stager et al., 2006; Anderson
et al., 2007; Nylen et al., 2007); CD8+ T cells (Belkaid et al., 2002),
B cells (Ronet et al., 2010), NK cells (Maroof et al., 2008), regula-
tory DCs (Svensson et al., 2004), macrophages (Miles et al., 2005),
and neutrophils (McFarlane et al., 2008). In patients, functional
Treg cells could be found in the skin lesions of patients with LCL.
These cells expressed phenotypic markers of Treg cells, includ-
ing CD25, CTLA-4, Foxp3, and GITR (glucocorticoid-induced
tumor necrosis factor receptor), and were able to produce large
amounts of IL-10 and TGF-β. CD4+CD25+ T cells derived from
the lesions of patients with LCL suppressed the PHA-induced
proliferative T cell responses of allogeneic PBMCs from healthy
controls (Campanelli et al., 2006). These ﬁndings suggest that
functional Treg cells accumulate at sites of Leishmania infection
in humans and possibly contribute to the local control of effector
T cell functions.
Another important immunosuppressive cytokine involved is
TGF-β. This cytokine has different effects on cells in the immune
system, including down-regulation of certain macrophage func-
tions. As commented earlier, this cytokine is produced by
macrophages present in the lesions of mice infected with L. ama-
zonensis (Barral-Netto et al., 1992). Human macrophages produce
active TGF-β after infection with L. amazonensis, L. chagasi,
and L. braziliensis. The addition of this cytokine to cultures of
L. braziliensis-infected macrophages led to an increase in parasite
numbers compared tountreated cultures. Fibroblasts in thedermis
could be immunostained for TGF-β, as could inﬂammatory cells
from the biopsies of human lesions on occasion – mainly from
patients with early cutaneous leishmaniasis (less than 2 months
following ulcer development) and in cases of active mucosal leish-
maniasis (Barral et al., 1995b). These results suggest that this
cytokine could be important for the establishment of infection
and as a feedback mechanism following the development of an
acute inﬂammatory response.
EXPERIMENTAL INFECTION WITH L. BRAZILIENSIS:
INSIGHTS INTO HUMAN PATHOGENESIS?
Initial studies conducted with inbred mice infected with L.
braziliensis revealed a broad range of responses. AKR/J and CBA/J
mice showedonly amild and transient swelling of the nose. SWR/J,
C57L/J, A/J, A/HeJ, and DBA/1J mice showed initial nodules,
which eventually healed. In contrast, BALB/cJ mice were con-
sidered susceptible based on progressive dermal lesions (Childs
et al., 1984). However, analysis of the immune response has
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shown that L. braziliensis-infected BALB/c mice produce less IL-4
than L. major-infected mice, and treating L. braziliensis-infected
BALB/c mice with anti-IFN-γ signiﬁcantly enhanced lesion size
and prevented mice from resolving the infection (DeKrey et al.,
1998). These authors suggest that an IFN-γ-dependent mecha-
nism is responsible for killing L. braziliensis in BALB/c mice and
that the weak infectivity of L. braziliensis in this mouse strain may
be due to the inability of the parasite to elicit a strong and sus-
tained IL-4 production. In a recent study, mice inoculated with
an antimony-resistant L. braziliensis strain displayed an increased
IL-4 response and elevated Arginase I expression (Costa et al.,
2011). Treatment with an anti-IL-4 monoclonal antibody resulted
in decreased lesion thickness and parasite load. Therefore, the
capacity of L. braziliensis isolates to induce a Th2-type response,
characterized by presence of IL-4, contributes to the virulence and
severity of disease.
Using the footpad model of infection, we showed that mice
infected with a L. braziliensis strain from Ceará (H3227) devel-
oped detectable lesions, whereas mice infected with a different
strain (BA788), isolated in Bahia, did not (Indiani de Oliveira
et al., 2004). Early after parasite inoculation, lymph node cells
from BA788-parasitized mice produced higher levels of IFN-γ
and had higher numbers of NK cells than H3227-infected mice.
Importantly, the L. braziliensis strain from Ceará (H3227) is
genotypically different from the L. braziliensis strain from Bahia
(BA788). Therefore, variation in the pathogenicity of these dif-
ferent L. braziliensis strains correlated with their genetic diversity.
Interestingly, in Ceará state, where the H3227 L. braziliensis iso-
late was obtained, prominent lymphadenopathy can precede skin
lesion appearance (Sousa Ade et al., 1995), suggesting that impor-
tant correlates can be drawn from the mouse model. In a subse-
quent study using the same two strains, the H3227 L. braziliensis
strain induced signiﬁcantly stronger cellular recruitment than the
BA788 strain, which correlated with higher expression of CCL2,
CCL3, and CXCL1 (Teixeira et al., 2005). In contrast, L. brazilien-
sis BA788 signiﬁcantly up-regulated CXCL10 expression, which
correlated with earlier IFN-γ production and with a higher
number of NKcells present at the infection site (Indiani deOliveira
et al., 2004).
BALB/c mice infected with a Leishmania strain isolated from a
ML patient developed a rapidly progressing and widely metastatic
disease resembling diffuse cutaneous leishmaniasis (Barral et al.,
1983). Although C57BL/6 mice initially contained parasite mul-
tiplication and appeared clinically cured, subsequent disease
developed that was characterized by distinctive ulcerative metas-
tases and destruction of the nasal region, similar to what is
observed in ML. Disease development in these mouse strains was
associated with a decrease in cell-mediated immunity, as mon-
itored by delayed type hypersensitivity and lymphoproliferative
responses. Footpad injection of metacyclic L. braziliensis into
C57BL/6 mice conﬁrmed the initial ﬁndings regarding disease
outcome in this mouse strain, as the mice control infection and
parasite multiplication in the draining lymph nodes (Maioli et al.,
2004). This phenotype was associated with increased levels of
IFN-γ and TNF-α and a superior lymphoproliferative response.
Importantly, in the same study, the authors demonstrated that
L. amazonensis infection leads to chronic lesion development with
elevated parasite numbers and a decreased cellular response, high-
lighting the differences in immune regulation induced by the
distinct New World Leishmania species.
As has been thoroughly described in the literature, mice from
BALB strains are highly susceptible to L. major infection, and this
susceptibility is linked to a predominant Th2 response character-
ized by the presence of IL-4 (reviewed in Belkaid et al., 2002).
In a comparative study, BALB/c mice infected subcutaneously
with L. braziliensis developed small, nodular lesions that self-
healed, in contrast to L. major-infected BALB/c mice, which
displayed progressive ulcers (Rocha et al., 2007). This pheno-
type was conﬁrmed by intradermal infection with L. braziliensis,
after which mice develop ulcerated lesions (similar to the lesions
that develop upon natural infection) that heal spontaneously
(de Moura et al., 2005). In this model, a mixed Th1/Th2 immune
response was observed that was characterized by the presence
of IFN-γ, IL-4, and IL-10-secreting cells, which is distinct from
the Th2-polarized response observed following L. major infec-
tion. Interestingly, parasites are cleared from the infection site
following lesion healing but persist within draining lymph nodes,
suggesting that immunoregulatory mechanisms allow for parasite
survival. Indeed, the presence of CD4+CD25+ T cells expressing
regulatory markers such as Foxp3, GITR, and CD103 has been
described following L. braziliensis infection (Costa et al., 2011;
Falcão et al., 2012).
A similar phenotype was also observed in C57BL/6 mice.
The “resistance” observed in L. braziliensis-infected mice of this
strain was associated with signiﬁcantly lower IL-4 and IL-13
production in parallel with increased presence of IFN-γ and
iNOS. Previous work has shown that IFN-γ−/− mice infected
with L. braziliensis develop uncontrolled lesions (DeKrey et al.,
1998), while IL-12p40−/− mice, which lack both IL-12 and IL-23,
develop chronic lesions (de Souza-Neto et al., 2004). As lym-
phocytes from the latter produce decreased levels of IFN-γ, this
further implicates IFN-γ in the control of L. braziliensis infec-
tion. These results were conﬁrmed by infecting IL-12p35−/−
mice, which lack IL-12 only. These mice display uncontrolled
lesions, as do IL-12p35p40−/− mice (Rocha et al., 2007). A similar
phenotype was observed following infection of STAT4−/− mice,
implicating IL-12 in the immune response to L. braziliensis. Lastly,
iNOs−/− mice develop progressive non-healing lesions and have
an increased parasite loadwithin the draining lymphnodes (Rocha
et al., 2007). The lesions self heal in mice lacking gp91phox, indi-
cating that only iNOS is essential for controlling L. braziliensis
infection.
NEWWORLD LEISHMANIASIS AND THE ROLE OF
SAND FLY SALIVA
Several attempts have been made to reproduce the biology of
natural transmission, taking into account parasite load (sand
ﬂies inoculate low numbers of parasites), the presence of saliva
(parasites are injected into the host’s skin in conjunction with
sand ﬂy saliva) and the site of inoculation (parasites are injected
by the sand ﬂy into the dermal compartments of the skin).
BALB/c mice inoculated in the ear dermis with L. brazilien-
sis develop ulcerated lesions (de Moura et al., 2005), but co-
inoculation of parasites plus sand ﬂy saliva exacerbates infection
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(Samuelson et al., 1991), which is associated with elevated IL-4
production (Lima and Titus, 1996). Similarly, co-inoculation with
L. amazonensis and sand ﬂy saliva also exacerbates infection; how-
ever, in this context, it was associated with increased IL-10 levels
(Norsworthy et al., 2004). Moreover, mice injected with parasites
in the presence of saliva developed lesions with heavily parasitized
epithelioid macrophages, persistent neutrophils and eosinophils,
and minimal ﬁbroplasia, indicating that sand ﬂy saliva modiﬁes
the inﬂammatory response during infection with L. brazilien-
sis. Of note, this disease exacerbation in the presence of saliva
was dependent on the sand ﬂy species, as co-inoculation with
L. braziliensis and Lu. whitmani saliva led to the development of
lesions that heal spontaneously (Bezerra and Teixeira, 2001).
Pre-exposure to saliva or to bites from uninfected sand ﬂies
has been shown to result in protection against subsequent infec-
tion with New World species such as L. amazonensis (Thiakaki
et al., 2005) and L. chagasi (Gomes et al., 2008). In contrast, pre-
exposure to Lu. intermedia saliva enhanced L. braziliensis infection
in the mouse model; additionally, disease exacerbation was cor-
related with the generation of a Th2 response, as evidenced by a
reduction in the IFN-γ/IL-4 ratio (de Moura et al., 2007). Impor-
tantly, individuals with active LCL showed stronger humoral
immune responses to Lu. intermedia saliva than control sub-
jects, a ﬁnding also true for Old World LCL (Rohousova et al.,
2005). These data indicate an association between disease and the
immune response to Lu. intermedia saliva in humans. As men-
tioned earlier, sand ﬂy saliva modiﬁes the inﬂammatory response
to infection with L. braziliensis (Lima and Titus, 1996). Indeed,
pre-treatment of human monocytes with Lu. intermedia saliva
followed by L. braziliensis infection led to a signiﬁcant increase in
TNF-α, IL-6, and IL-8 production (Menezes et al., 2008), indicat-
ing the capacity of Lu. intermedia saliva to alter the inﬂammatory
milieu. StimulationwithLu. intermedia salivary proteinsmarkedly
increased leukocyte recruitment, and mice immunized with Lu.
intermedia saliva showed a concomitant increase in CXCL1, CCL2,
CCL4, and TNF-α expression (de Moura et al., 2010). Upon stim-
ulation with L. braziliensis, however, IL-10 up-regulation was
observed, conﬁrming that pre-exposure to Lu. intermedia is able
to modify the inﬂammatory environment and, in doing so, favors
L. braziliensis establishment.
Several groups have examined the possibility of vaccination
using salivary antigens. Immunizationwith aDNAplasmid coding
for the SP15 Phlebotomus papatasi protein was effective in pro-
viding protection against infection by L. major (Valenzuela et al.,
2001). In parallel, we have shown that hamsters immunized with
a DNA plasmid coding for LJM19, a protein present in Lu. longi-
palpis saliva, were protected against the development of visceral
leishmaniasis (Gomes et al., 2008). LJM19-immunized hamsters
maintained a low parasite load that correlated with high IFN-γ/
TGF-β ratio and iNOS production. Importantly, a delayed-type
hypersensitivity (DTH) response with high expression of IFN-γ
was also detectible in the skin of LJM19-immunized animals.
These studies suggested that a DTH response generated against
salivary antigens such as SP15 or LJM19 might be the mechanism
underlying protective anti-Leishmania immunity. Based on this
hypothesis, we have shown that immunization with a DNA plas-
mid coding for LJM19, a protein present in Lu. longipalpis saliva,
conferred protection against L. braziliensis (Tavares et al., 2011).
These results suggest the possibility of using salivary antigens to
generate protection against different species of Leishmania.
CONCLUDING REMARKS
Although Leishmania infection has been widely used to elucidate
many aspects of the immune response to intracellular pathogens,
we still do not fully understand the immunopathogenesis of the
human disease. It is clear that LCL and ML caused by L. brazilien-
sis are diseases in which immunoregulation, rather than parasite
multiplication per se, plays a major role. Moreover, DCL caused
by L. amazonensis is a disease that completely lacks a cellular
immune response. Collectively, these major differences urge for
more studies focused on human immunology. The experimental
mouse intradermal infection model using L. braziliensis recapitu-
lates many aspects of the human infection; as such, it will prove a
useful tool for dissecting aspects of both the innate and the adap-
tive immune response to this important representative of New
World leishmaniasis.
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